文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

调节性 T 细胞产生的腺苷通过 A2aR 通路诱导胃癌中的 CD8 T 细胞耗竭。

Adenosine Generated by Regulatory T Cells Induces CD8 T Cell Exhaustion in Gastric Cancer through A2aR Pathway.

机构信息

Department of Gastrointestinal Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.

The Affiliated Drum Tower Clinical College of Nanjing Medical University, Nanjing, China.

出版信息

Biomed Res Int. 2019 Dec 14;2019:4093214. doi: 10.1155/2019/4093214. eCollection 2019.


DOI:10.1155/2019/4093214
PMID:31930120
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6942766/
Abstract

BACKGROUND: Adenosine, derived from the degradation of ATP via ectonucleotidases CD39 and CD73, is a critical immunosuppressive metabolite in the hypoxic microenvironment of tumor tissue. Adenosine signaling via A2aR can inhibit the antitumor immune response of CD8 T cells. CD39 and CD73 high-expressing Tregs play a critical role in tumor immune evasion of gastric cancer (GC). The present study investigated the underlying mechanism by which Tregs suppress antitumor immune responses in GC. MATERIALS AND METHODS: Fifty-two GC samples were collected, and the frequency of FoxP3 Tregs and CD8 T cells and density ratios of A2aR/CD8 T cells, CD39/FoxP3 Tregs, and CD73/FoxP3 Tregs in GC were assessed with multiplex immunofluorescence. The expression of FoxP3 and A2aR in GC tissues was also detected by the immunoblotting assay. We next investigated the relationship between density of FoxP3 Tregs, ratio of A2aR/CD8 T cells, and clinicopathological parameters. At the same time, Tregs and CD8 T cells were isolated from peripheral blood of five GC patients, and the antagonists of CD39 and CD73 were used to assess the ability of Tregs to decompose ATP into adenosine. In addition, we cocultured CD8 T cells and Tregs with antagonists of AR and AR in order to examine the alterations in immune function of CD8 T cells. RESULTS: The density of both FoxP3 Tregs and A2aR/CD8 T cells was higher in GC tissue compared to peritumoral normal tissue and significantly correlated with the TNM stage, lymph node metastasis, and distant metastasis of GC. The process of Treg hydrolysis of ATP into adenosine was blocked by the antagonists of CD39 and CD73. In addition, Tregs could induce apoptosis and inhibit proliferation of CD8 T cells, while this effect could be obviously reduced by applying the antagonist of AR or ARAR. Moreover, IFN-, TNF-, and perforin generated by CD8 T cells could also be inhibited through the adenosine A2aR pathway. CONCLUSIONS: The FoxP3 Tregs and A2aR/CD8 T cells were excessively infiltrated in GC tissue. Tregs from GC can decompose ATP to adenosine and in turn induce apoptosis and inhibit the proliferation of CD8 T cells through the A2aR pathway, further leading to immune escape of GC.

摘要

背景:腺苷是由细胞外核苷酸酶 CD39 和 CD73 降解 ATP 产生的,是肿瘤组织低氧微环境中一种关键的免疫抑制代谢物。通过 A2aR 信号传导的腺苷可以抑制 CD8 T 细胞的抗肿瘤免疫反应。CD39 和 CD73 高表达的 Tregs 在胃癌(GC)的肿瘤免疫逃逸中起着关键作用。本研究探讨了 Tregs 抑制 GC 中抗肿瘤免疫反应的潜在机制。

材料和方法:收集了 52 例 GC 样本,通过多重免疫荧光法评估了 FoxP3 Tregs 和 CD8 T 细胞的频率以及 A2aR/CD8 T 细胞、CD39/FoxP3 Tregs 和 CD73/FoxP3 Tregs 的密度比。还通过免疫印迹法检测了 GC 组织中 FoxP3 和 A2aR 的表达。接下来,我们研究了 FoxP3 Tregs 的密度、A2aR/CD8 T 细胞的比值与临床病理参数之间的关系。同时,从 5 例 GC 患者的外周血中分离 Tregs 和 CD8 T 细胞,并使用 CD39 和 CD73 的拮抗剂来评估 Tregs 将 ATP 分解为腺苷的能力。此外,我们将 CD8 T 细胞和 Tregs 与 AR 和 AR 的拮抗剂共培养,以检查 CD8 T 细胞免疫功能的变化。

结果:与肿瘤周围正常组织相比,GC 组织中 FoxP3 Tregs 和 A2aR/CD8 T 细胞的密度更高,且与 GC 的 TNM 分期、淋巴结转移和远处转移显著相关。CD39 和 CD73 的拮抗剂阻断了 Treg 将 ATP 水解为腺苷的过程。此外,Tregs 可诱导 CD8 T 细胞凋亡并抑制其增殖,而通过应用 AR 或 ARAR 的拮抗剂可明显降低这种作用。此外,CD8 T 细胞产生的 IFN-γ、TNF-α和穿孔素也可通过腺苷 A2aR 途径受到抑制。

结论:FoxP3 Tregs 和 A2aR/CD8 T 细胞在 GC 组织中过度浸润。GC 中的 Tregs 可以将 ATP 分解为腺苷,并通过 A2aR 途径诱导 CD8 T 细胞凋亡和抑制其增殖,进而导致 GC 的免疫逃逸。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/6942766/9275bf0e442b/BMRI2019-4093214.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/6942766/ba449f0f04c4/BMRI2019-4093214.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/6942766/cbf224ccfeb6/BMRI2019-4093214.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/6942766/30d776ba98e7/BMRI2019-4093214.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/6942766/9275bf0e442b/BMRI2019-4093214.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/6942766/ba449f0f04c4/BMRI2019-4093214.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/6942766/cbf224ccfeb6/BMRI2019-4093214.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/6942766/30d776ba98e7/BMRI2019-4093214.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/516d/6942766/9275bf0e442b/BMRI2019-4093214.004.jpg

相似文献

[1]
Adenosine Generated by Regulatory T Cells Induces CD8 T Cell Exhaustion in Gastric Cancer through A2aR Pathway.

Biomed Res Int. 2019-12-14

[2]
Phenotypical analysis of ectoenzymes CD39/CD73 and adenosine receptor 2A in CD4 CD25 Foxp3 regulatory T-cells in psoriasis.

Australas J Dermatol. 2018-2

[3]
Blockade of adenosine A2A receptor enhances CD8 T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma.

Mol Cancer. 2017-6-7

[4]
CD39/CD73/A2a Adenosine Metabolic Pathway: Targets for Moxibustion in Treating DSS-Induced Ulcerative Colitis.

Am J Chin Med. 2021

[5]
Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade.

J Immunother Cancer. 2020-5

[6]
Current perspectives and trends of CD39-CD73-eAdo/A2aR research in tumor microenvironment: a bibliometric analysis.

Front Immunol. 2024

[7]
Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity.

Cancer Immunol Immunother. 2011-6-3

[8]
Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.

Int J Mol Med. 2016-9

[9]
Targeting adenosine and regulatory T cells in cancer immunotherapy.

Hum Immunol. 2021-4

[10]
CD73 on T Cells Orchestrates Cardiac Wound Healing After Myocardial Infarction by Purinergic Metabolic Reprogramming.

Circulation. 2017-4-21

引用本文的文献

[1]
Hypoxic link between cancer cells and the immune system: The role of adenosine and lactate.

Oncol Res. 2025-7-18

[2]
Insights from Clinical Trials on A Adenosine Receptor Antagonists for Cancer Treatment.

ACS Pharmacol Transl Sci. 2025-5-2

[3]
Artificial intelligence-driven integration of single-cell RNA sequencing and transcriptome analysis to decipher APOE's role in gastric cancer prognosis and therapy.

Discov Oncol. 2025-3-13

[4]
The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas.

Cells. 2025-2-19

[5]
Neoantigen mRNA vaccines and AA receptor antagonism: A strategy to enhance T cell immunity.

Hum Vaccin Immunother. 2025-12

[6]
Elucidating the Mechanisms of Acquired Palbociclib Resistance via Comprehensive Metabolomics Profiling.

Curr Issues Mol Biol. 2025-1-2

[7]
Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies.

Exp Hematol Oncol. 2024-8-6

[8]
The role of CD8 T-cells in colorectal cancer immunotherapy.

Heliyon. 2024-6-15

[9]
Apoptosis, a Metabolic "Head-to-Head" between Tumor and T Cells: Implications for Immunotherapy.

Cells. 2024-5-27

[10]
Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion.

Biology (Basel). 2024-4-28

本文引用的文献

[1]
PD-L1 expression combined with microsatellite instability/CD8+ tumor infiltrating lymphocytes as a useful prognostic biomarker in gastric cancer.

Sci Rep. 2019-3-15

[2]
CD39 regulatory T cells accumulate in colon adenocarcinomas and display markers of increased suppressive function.

Oncotarget. 2018-12-11

[3]
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial.

Lancet. 2018-6-4

[4]
Cancer statistics, 2018.

CA Cancer J Clin. 2018-1-4

[5]
A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment.

Cancer Res. 2017-12-11

[6]
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet. 2017-10-6

[7]
Gastric cancer tissue-derived mesenchymal stem cells impact peripheral blood mononuclear cells via disruption of Treg/Th17 balance to promote gastric cancer progression.

Exp Cell Res. 2017-12-1

[8]
Cervical cancer cells suppress effector functions of cytotoxic T cells through the adenosinergic pathway.

Cell Immunol. 2017-10

[9]
Tumoral FOXP3 expression is associated with favorable clinicopathological variables and good prognosis in gastric adenocarcinoma: the tumor suppressor function of tumoral FOXP3 is related with the P21 expression in gastric adenocarcinoma.

Hum Pathol. 2017-10

[10]
Changing Trends in Stomach Cancer Throughout the World.

Curr Gastroenterol Rep. 2017-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索